Successful Therapy of Crohn's Disease-Associated Pulmonary Necrobiotic Nodules on Ustekinumab Therapy

Am J Gastroenterol. 2020 Apr;115(4):632-634. doi: 10.14309/ajg.0000000000000571.

Authors

Ingo Ganzleben^{1

2}, Simon Hirschmann^{1

2}, Julia Köhler³, Florian S Fuchs^{1

2}, Ralf J Rieker⁴, Eva Baer^{1

2}, Entcho Klenske^{1

2}, Daniel Nagore⁵, Markus F Neurath^{1

2}, Raja Atreya^{1

2}

Affiliations

¹ Department of Medicine 1, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
² Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany.
³ Department of Radiology, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
⁴ Department of Pathology, University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.
⁵ Progenika Biopharma SA, R&D, Derio, Spain.

PMID: 32149778
DOI: 10.14309/ajg.0000000000000571

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Crohn Disease / complications*
Dermatologic Agents / therapeutic use*
Erythema Nodosum / drug therapy*
Erythema Nodosum / etiology*
Female
Humans
Lung Diseases / diagnostic imaging
Lung Diseases / drug therapy*
Lung Diseases / etiology*
Necrobiotic Disorders / diagnostic imaging
Necrobiotic Disorders / drug therapy*
Necrobiotic Disorders / etiology*
Ustekinumab / therapeutic use*

Substances

Dermatologic Agents
Ustekinumab